Nasus Pharma outlines 2026 clinical milestones for NS002 epinephrine Dec 22, 2025 08:00AM
Citizens Starts Nasus Pharma Ltd (NSRX) at Market Outperform Dec 18, 2025 02:38AM
Nasus Pharma expands Aptar partnership for NS002 epinephrine development Oct 8, 2025 08:04AM
Laidlaw Starts Nasus Pharma Ltd (NSRX) at Buy Sep 29, 2025 01:54AM
Nasus Pharma (NSRX) Opens At $8, IPO Priced At $8 Aug 13, 2025 10:16AM


Jul 28, 2025 09:56AM Nasus Pharma (NSRX) Files for 1.25M Share IPO at $8-$10/sh
Jul 9, 2025 04:01PM Nasus Pharma (NSRX) Files for 1M Share IPO at $10-$12/sh